{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:10:36Z","timestamp":1794003036935,"version":"4.8.0"},"reference-count":211,"publisher":"Annual Reviews","issue":"1","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,27]]},"abstract":"<jats:p>Type III interferons are essential immune mediators playing pleiotropic roles during health and disease. In this review, we highlight the molecular and cellular pathways that lead to the production of type III interferons. We also describe their exquisite capacity to act at primary barrier tissues such as those in the intestine, airways, urogenital tract, and skin, as well as to act in other organs such as the liver and thymus. We characterize the activity of type III interferons on distinct cell types in different tissues and organs and detail their impact for the host in the context of viral, bacterial, helminth, and fungal infections. Additionally, we illustrate roles of type III interferons during the development of inflammatory diseases such as inflammatory bowel disease, acute respiratory distress syndrome, asthma, solid tumors, and lupus. Overall, we summarize the dichotomous roles played by this class of interferons and highlight the knowledge gaps that must be addressed to harness type III interferons against multiple human diseases.<\/jats:p>","DOI":"10.1146\/annurev-immunol-083024-032807","type":"journal-article","created":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T19:40:58Z","timestamp":1767382858000},"page":"121-147","source":"Crossref","is-referenced-by-count":5,"title":["Molecular, Cellular, Tissue, and Organismal Functions of Type III Interferons"],"prefix":"10.1146","volume":"44","author":[{"given":"Daniel","family":"Boehmer","sequence":"first","affiliation":[{"name":"1Division of Immunology and Division of Gastroenterology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA; email: ivan.zanoni@childrens.harvard.edu"},{"name":"2Department of Medicine II, LMU University Hospital, LMU Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreya","family":"Ghosh","sequence":"additional","affiliation":[{"name":"1Division of Immunology and Division of Gastroenterology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA; email: ivan.zanoni@childrens.harvard.edu"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kautilya K.","family":"Jena","sequence":"additional","affiliation":[{"name":"1Division of Immunology and Division of Gastroenterology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA; email: ivan.zanoni@childrens.harvard.edu"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Svensson","family":"Akusj\u00e4rvi","sequence":"additional","affiliation":[{"name":"1Division of Immunology and Division of Gastroenterology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA; email: ivan.zanoni@childrens.harvard.edu"},{"name":"3Division of Immunology and Respiratory Medicine, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden"},{"name":"4Department of Clinical Immunology and Transfusion Medicine, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Zanoni","sequence":"additional","affiliation":[{"name":"1Division of Immunology and Division of Gastroenterology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA; email: ivan.zanoni@childrens.harvard.edu"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22","reference":[{"issue":"17","key":"B1","doi-asserted-by":"crossref","first-page":"4480","DOI":"10.1016\/j.cell.2025.06.044","article-title":"Interferons in health and disease","volume":"188","year":"2025","journal-title":"Cell"},{"issue":"927","key":"B2","first-page":"258","article-title":"Virus interference. I. The interferon","volume":"147","year":"1957","journal-title":"Proc. R. Soc. B"},{"issue":"927","key":"B3","first-page":"268","article-title":"Virus interference. II. Some properties of interferon","volume":"147","year":"1957","journal-title":"Proc. R. Soc. B"},{"issue":"6693","key":"B4","doi-asserted-by":"crossref","first-page":"eadl2016","DOI":"10.1126\/science.adl2016","article-title":"Interferon-\u03b3 and infectious diseases: lessons and prospects","volume":"384","year":"2024","journal-title":"Science"},{"issue":"1","key":"B5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ni875","article-title":"IFN-\u03bbs mediate antiviral protection through a distinct class II cytokine receptor complex","volume":"4","year":"2003","journal-title":"Nat. Immunol."},{"issue":"1","key":"B6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/ni873","article-title":"IL-28, IL-29 and their class II cytokine receptor IL-28R","volume":"4","year":"2003","journal-title":"Nat. Immunol."},{"issue":"2","key":"B7","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ng.2521","article-title":"A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus","volume":"45","year":"2013","journal-title":"Nat. Genet."},{"key":"B8","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/s41467-022-28645-6","article-title":"Identification and establishment of type IV interferon and the characterization of interferon-\u03c5 including its class II cytokine receptors IFN-\u03c5R1 and IL-10R2","volume":"13","year":"2022","journal-title":"Nat. Commun."},{"key":"B9","first-page":"209","article-title":"Evolution of interferons and interferon receptors","volume":"8","year":"2017","journal-title":"Front. Immunol."},{"key":"B10","doi-asserted-by":"crossref","first-page":"102427","DOI":"10.1016\/j.coi.2024.102427","article-title":"In search of a function for human type III interferons: insights from inherited and acquired deficits","volume":"87","year":"2024","journal-title":"Curr. Opin. Immunol."},{"key":"B11","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.3389\/fimmu.2019.01558","article-title":"Discovery of all three types in cartilaginous fishes enables phylogenetic resolution of the origins and evolution of interferons","volume":"10","year":"2019","journal-title":"Front. Immunol."},{"key":"B12","doi-asserted-by":"crossref","first-page":"104624","DOI":"10.1016\/j.dci.2022.104624","article-title":"Molecular diversity and functional implication of amphibian interferon complex: remarking immune adaptation in vertebrate evolution","volume":"140","year":"2023","journal-title":"Dev. Comp. Immunol."},{"issue":"13","key":"B13","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1084\/jem.20111680","article-title":"Evolutionary genetic dissection of human interferons","volume":"208","year":"2011","journal-title":"J. Exp. Med."},{"issue":"10","key":"B14","doi-asserted-by":"crossref","first-page":"e1004681","DOI":"10.1371\/journal.pgen.1004681","article-title":"Selection on a variant associated with improved viral clearance drives local, adaptive pseudogenization of interferon lambda 4 (IFNL4)","volume":"10","year":"2014","journal-title":"PLOS Genet"},{"key":"B15","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/s41467-025-56119-y","article-title":"Structural studies of the IFN\u03bb4 receptor complex using cryoEM enabled by protein engineering","volume":"16","year":"2025","journal-title":"Nat. Commun."},{"issue":"9","key":"B16","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/ni.3211","article-title":"TH17 cells promote microbial killing and innate immune sensing of DNA via interleukin 26","volume":"16","year":"2015","journal-title":"Nat. Immunol."},{"issue":"44","key":"B17","doi-asserted-by":"crossref","first-page":"e2409684121","DOI":"10.1073\/pnas.2409684121","article-title":"Interferon lambda 4 is a gut antimicrobial protein","volume":"121","year":"2024","journal-title":"PNAS"},{"key":"B18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev-immunol-032414-112240","article-title":"Innate immune pattern recognition: a cell biological perspective","volume":"33","year":"2015","journal-title":"Annu. Rev. Immunol."},{"key":"B19","article-title":"ARIES domains: functional signaling units of type I interferon responses","year":"2025","journal-title":"FEBS J"},{"issue":"9","key":"B20","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.4049\/jimmunol.1700250","article-title":"Type III IFNS are commonly induced by bacteria-sensing TLRs and reinforce epithelial barriers during infection","volume":"199","year":"2017","journal-title":"J. Immunol."},{"issue":"7","key":"B21","doi-asserted-by":"crossref","first-page":"e1000500","DOI":"10.1371\/journal.ppat.1000500","article-title":"NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to Mycobacterium tuberculosis","volume":"5","year":"2009","journal-title":"PLOS Pathog"},{"issue":"6","key":"B22","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.immuni.2013.05.010","article-title":"Interferon-\u03b2 production via Dectin-1-Syk-IRF5 signaling in dendritic cells is crucial for immunity to C. albicans","volume":"38","year":"2013","journal-title":"Immunity"},{"issue":"4","key":"B23","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.cell.2022.01.009","article-title":"An adjuvant strategy enabled by modulation of the physical properties of microbial ligands expands antigen immunogenicity","volume":"185","year":"2022","journal-title":"Cell"},{"issue":"8","key":"B24","doi-asserted-by":"crossref","first-page":"e20221156","DOI":"10.1084\/jem.20221156","article-title":"The Z-nucleic acid sensor ZBP1 in health and disease","volume":"220","year":"2023","journal-title":"J. Exp. Med."},{"issue":"6262","key":"B25","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1126\/science.aab3145","article-title":"Nlrp6 regulates intestinal antiviral innate immunity","volume":"350","year":"2015","journal-title":"Science"},{"issue":"1","key":"B26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41564-019-0594-3","article-title":"Asymmetric distribution of TLR3 leads to a polarized immune response in human intestinal epithelial cells","volume":"5","year":"2019","journal-title":"Nat. Microbiol."},{"issue":"8","key":"B27","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/ni.2915","article-title":"Diverse intracellular pathogens activate type III interferon expression from peroxisomes","volume":"15","year":"2014","journal-title":"Nat. Immunol."},{"issue":"11","key":"B28","doi-asserted-by":"crossref","first-page":"e1005264","DOI":"10.1371\/journal.ppat.1005264","article-title":"Activation of type I and III interferon response by mitochondrial and peroxisomal MAVS and inhibition by hepatitis C virus","volume":"11","year":"2015","journal-title":"PLOS Pathog"},{"issue":"28","key":"B29","doi-asserted-by":"crossref","first-page":"11564","DOI":"10.1073\/pnas.0904477106","article-title":"The role of transposable elements in the regulation of IFN-\u03bb1 gene expression","volume":"106","year":"2009","journal-title":"PNAS"},{"issue":"10","key":"B30","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1084\/jem.20121401","article-title":"Respiratory virus\u2013induced EGFR activation suppresses IRF1-dependent interferon \u03bb and antiviral defense in airway epithelium","volume":"210","year":"2013","journal-title":"J. Exp. Med."},{"issue":"11","key":"B31","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.4049\/jimmunol.1003988","article-title":"Regulation of IFN-\u03bb1 promoter activity (IFN-\u03bb1\/IL-29) in human airway epithelial cells","volume":"187","year":"2011","journal-title":"J. Immunol."},{"issue":"6","key":"B32","first-page":"e02540","article-title":"The TLR3\/IRF1\/type III IFN axis facilitates antiviral responses against enterovirus infections in the intestine","volume":"11","year":"2020","journal-title":"mBio"},{"issue":"4","key":"B33","doi-asserted-by":"crossref","first-page":"e1004782","DOI":"10.1371\/journal.ppat.1004782","article-title":"Leukocyte-derived IFN-\u03b1\/\u03b2 and epithelial IFN-\u03bb constitute a compartmentalized mucosal defense system that restricts enteric virus infections","volume":"11","year":"2015","journal-title":"PLOS Pathog"},{"issue":"7","key":"B34","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/ni.3180","article-title":"Interferon-\u03bb and interleukin 22 act synergistically for the induction of interferon-stimulated genes and control of rotavirus infection","volume":"16","year":"2015","journal-title":"Nat. Immunol."},{"issue":"3","key":"B35","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.immuni.2017.02.017","article-title":"The IFN-\u03bb-IFN-\u03bbR1-IL-10R\u03b2 complex reveals structural features underlying type III IFN functional plasticity","volume":"46","year":"2017","journal-title":"Immunity"},{"issue":"10","key":"B36","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/ni.3821","article-title":"IFN-\u03bb suppresses intestinal inflammation by non-translational regulation of neutrophil function","volume":"18","year":"2017","journal-title":"Nat. Immunol."},{"issue":"4","key":"B37","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3892\/ijmm.2012.1064","article-title":"Role of the p38 MAPK signaling pathway in mediating interleukin-28A-induced migration of UMUC-3 cells","volume":"30","year":"2012","journal-title":"Int. J. Mol. Med."},{"issue":"59","key":"B38","doi-asserted-by":"crossref","first-page":"eabd5318","DOI":"10.1126\/sciimmunol.abd5318","article-title":"Selective Janus kinase inhibition preserves interferon-\u03bb-mediated antiviral responses","volume":"6","year":"2021","journal-title":"Sci. Immunol."},{"key":"B39","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1038\/s41467-019-10970-y","article-title":"A molecular switch from STAT2-IRF9 to ISGF3 underlies interferon-induced gene transcription","volume":"10","year":"2019","journal-title":"Nat. Commun."},{"key":"B40","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1146\/annurev-virology-092818-015756","article-title":"Interferon-stimulated genes: What do they all do?","volume":"6","year":"2019","journal-title":"Annu. Rev. Virol."},{"issue":"9","key":"B41","doi-asserted-by":"crossref","first-page":"e2220120120","DOI":"10.1073\/pnas.2220120120","article-title":"Type III interferon drives thymic B cell activation and regulatory T cell generation","volume":"120","year":"2023","journal-title":"PNAS"},{"issue":"97","key":"B42","doi-asserted-by":"crossref","first-page":"eadp1139","DOI":"10.1126\/sciimmunol.adp1139","article-title":"Sterile production of interferons in the thymus affects T cell repertoire selection","volume":"9","year":"2024","journal-title":"Sci. Immunol."},{"issue":"6","key":"B43","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1084\/jem.20140995","article-title":"IFN-\u03bb resolves inflammation via suppression of neutrophil infiltration and IL-1\u03b2 production","volume":"212","year":"2015","journal-title":"J. Exp. Med."},{"issue":"284","key":"B44","first-page":"284ra59","article-title":"Interferon-\u03bb restricts West Nile virus neuroinvasion by tightening the blood-brain barrier","volume":"7","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"B45","doi-asserted-by":"crossref","first-page":"6992","DOI":"10.1038\/s41467-022-34709-4","article-title":"Interferon-\u03bb treatment accelerates SARS-CoV-2 clearance despite age-related delays in the induction of T cell immunity","volume":"13","year":"2022","journal-title":"Nat. Commun."},{"key":"B46","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1038\/s41467-025-58220-8","article-title":"Type III interferon primes pDCs for TLR7 activation and antagonizes immune suppression mediated by TGF-\u03b2 and PGE2","volume":"16","year":"2025","journal-title":"Nat. Commun."},{"issue":"10","key":"B47","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1084\/jem.20140280","article-title":"Human TYK2 deficiency: mycobacterial and viral infections without hyper-IgE syndrome","volume":"212","year":"2015","journal-title":"J. Exp. Med."},{"issue":"11","key":"B48","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1002\/eji.201646519","article-title":"Tyrosine kinase 2 is not limiting human antiviral type III interferon responses","volume":"46","year":"2016","journal-title":"Eur. J. Immunol."},{"issue":"806","key":"B49","doi-asserted-by":"crossref","first-page":"eadf5494","DOI":"10.1126\/scisignal.adf5494","article-title":"Membrane-proximal motifs encode differences in signaling strength between type I and III interferon receptors","volume":"16","year":"2023","journal-title":"Sci. Signal."},{"issue":"11","key":"B50","doi-asserted-by":"crossref","first-page":"e1007420","DOI":"10.1371\/journal.ppat.1007420","article-title":"Differential induction of interferon stimulated genes between type I and type III interferons is independent of interferon receptor abundance","volume":"14","year":"2018","journal-title":"PLOS Pathog"},{"issue":"4","key":"B51","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/hep.26657","article-title":"Dynamic expression profiling of type I and type III interferon-stimulated hepatocytes reveals a stable hierarchy of gene expression","volume":"59","year":"2014","journal-title":"Hepatology"},{"issue":"3","key":"B52","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.immuni.2019.07.007","article-title":"Differential activation of the transcription factor IRF1 underlies the distinct immune responses elicited by type I and type III interferons","volume":"51","year":"2019","journal-title":"Immunity"},{"issue":"14","key":"B53","doi-asserted-by":"crossref","first-page":"7749","DOI":"10.1128\/JVI.02438-06","article-title":"Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases","volume":"81","year":"2007","journal-title":"J. Virol."},{"issue":"21","key":"B54","first-page":"e00603","article-title":"Selective interferon responses of intestinal epithelial cells minimize tumor necrosis factor alpha cytotoxicity","volume":"94","year":"2020","journal-title":"J. Virol."},{"issue":"1","key":"B55","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/sj.gene.6364348","article-title":"Modulation of the human cytokine response by interferon lambda-1 (IFN-\u03bb1\/IL-29)","volume":"8","year":"2007","journal-title":"Genes Immun"},{"issue":"1","key":"B56","first-page":"e01939","article-title":"Lambda interferon restructures the nasal microbiome and increases susceptibility to Staphylococcus aureus superinfection","volume":"7","year":"2016","journal-title":"mBio"},{"issue":"6","key":"B57","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.3390\/ijms20061445","article-title":"Differential regulation of type I and type III interferon signaling","volume":"20","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B58","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3389\/fimmu.2017.00459","article-title":"2017. Type I and type III interferons display different dependency on mitogen-activated protein kinases to mount an antiviral state in the human gut","volume":"8","journal-title":"Front. Immunol."},{"issue":"12","key":"B59","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.4049\/jimmunol.2100876","article-title":"IFN-\u03bb diminishes the severity of viral bronchiolitis in neonatal mice by limiting NADPH oxidase\u2013induced PAD4-independent NETosis","volume":"208","year":"2022","journal-title":"J. Immunol."},{"issue":"2","key":"B60","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/gene.2008.87","article-title":"Human interferon-\u03bb3 is a potent member of the type III interferon family","volume":"10","year":"2009","journal-title":"Genes Immun"},{"key":"B61","doi-asserted-by":"crossref","first-page":"102425","DOI":"10.1016\/j.coi.2024.102425","article-title":"Regulation of host\/pathogen interactions in the gastrointestinal tract by type I and III interferons","volume":"87","year":"2024","journal-title":"Curr. Opin. Immunol."},{"issue":"4","key":"B62","doi-asserted-by":"crossref","first-page":"e1005600","DOI":"10.1371\/journal.ppat.1005600","article-title":"Distinct roles of type I and type III interferons in intestinal immunity to homologous and heterologous rotavirus infections","volume":"12","year":"2016","journal-title":"PLOS Pathog"},{"issue":"19","key":"B63","doi-asserted-by":"crossref","first-page":"7944","DOI":"10.1073\/pnas.1100552108","article-title":"IFN-\u03bb determines the intestinal epithelial antiviral host defense","volume":"108","year":"2011","journal-title":"PNAS"},{"issue":"7","key":"B64","first-page":"e02079","article-title":"Expression of Ifnlr1 on intestinal epithelial cells is critical to the antiviral effects of interferon lambda against norovirus and reovirus","volume":"91","year":"2017","journal-title":"J. Virol."},{"issue":"22","key":"B65","first-page":"e01073","article-title":"Disruption of type III interferon (IFN) genes Ifnl2 and Ifnl3 recapitulates loss of the type III IFN receptor in the mucosal antiviral response","volume":"93","year":"2019","journal-title":"J. Virol."},{"issue":"6219","key":"B66","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.1258100","article-title":"Interferon-\u03bb cures persistent murine norovirus infection in the absence of adaptive immunity","volume":"347","year":"2015","journal-title":"Science"},{"issue":"5","key":"B67","doi-asserted-by":"crossref","first-page":"e1011961","DOI":"10.1371\/journal.ppat.1011961","article-title":"Interferons and tuft cell numbers are bottlenecks for persistent murine norovirus infection","volume":"20","year":"2024","journal-title":"PLOS Pathog"},{"issue":"6","key":"B68","doi-asserted-by":"crossref","first-page":"111593","DOI":"10.1016\/j.celrep.2022.111593","article-title":"Tuft-cell-intrinsic and -extrinsic mediators of norovirus tropism regulate viral immunity","volume":"41","year":"2022","journal-title":"Cell Rep"},{"issue":"4","key":"B69","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.chom.2017.08.021","article-title":"Norovirus cell tropism is determined by combinatorial action of a viral non-structural protein and host cytokine","volume":"22","year":"2017","journal-title":"Cell Host Microbe"},{"issue":"37","key":"B70","doi-asserted-by":"crossref","first-page":"eadi2562","DOI":"10.1126\/sciadv.adi2562","article-title":"IFN-\u03bb derived from nonsusceptible enterocytes acts on tuft cells to limit persistent norovirus","volume":"9","year":"2023","journal-title":"Sci. Adv."},{"issue":"3","key":"B71","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.chom.2025.02.005","article-title":"Innate immune sensing of rotavirus by intestinal epithelial cells leads to diarrhea","volume":"33","year":"2025","journal-title":"Cell Host Microbe"},{"key":"B72","doi-asserted-by":"crossref","first-page":"102412","DOI":"10.1016\/j.coi.2024.102412","article-title":"Role of type-I and type-III interferons in gastrointestinal homeostasis and pathogenesis","volume":"86","year":"2024","journal-title":"Curr. Opin. Immunol."},{"issue":"20","key":"B73","doi-asserted-by":"crossref","first-page":"10322","DOI":"10.1128\/JVI.01186-09","article-title":"IRF3 inhibition by rotavirus NSP1 is host cell and virus strain dependent but independent of NSP1 proteasomal degradation","volume":"83","year":"2009","journal-title":"J. Virol."},{"issue":"17","key":"B74","first-page":"e00706","article-title":"Type III and not type I interferons efficiently prevent the spread of rotavirus in human intestinal epithelial cells","volume":"96","year":"2022","journal-title":"J. Virol."},{"key":"B75","doi-asserted-by":"crossref","first-page":"806084","DOI":"10.3389\/fmicb.2021.806084","article-title":"Enterovirus 71 antagonizes antiviral effects of type III interferon and evades the clearance of intestinal intraepithelial lymphocytes","volume":"12","year":"2022","journal-title":"Front. Microbiol."},{"issue":"7","key":"B76","doi-asserted-by":"crossref","first-page":"e9833","DOI":"10.15252\/msb.20209833","article-title":"Single-cell transcriptomics reveals immune response of intestinal cell types to viral infection","volume":"17","year":"2021","journal-title":"Mol. Syst. Biol."},{"issue":"7","key":"B77","doi-asserted-by":"crossref","first-page":"e1000108","DOI":"10.1371\/journal.ppat.1000108","article-title":"MDA-5 recognition of a murine norovirus","volume":"4","year":"2008","journal-title":"PLOS Pathog"},{"issue":"23","key":"B78","first-page":"e01368","article-title":"HOIL1 is essential for the induction of type I and III interferons by MDA5 and regulates persistent murine norovirus infection","volume":"92","year":"2018","journal-title":"J. Virol."},{"key":"B79","doi-asserted-by":"crossref","first-page":"7090","DOI":"10.1038\/ncomms8090","article-title":"Intestinal intraepithelial lymphocyte activation promotes innate antiviral resistance","volume":"6","year":"2015","journal-title":"Nat. Commun."},{"issue":"1","key":"B80","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41564-019-0602-7","article-title":"The intestinal regionalization of acute norovirus infection is regulated by the microbiota via bile acid-mediated priming of type III interferon","volume":"5","year":"2019","journal-title":"Nat. Microbiol."},{"issue":"1","key":"B81","doi-asserted-by":"crossref","first-page":"2447830","DOI":"10.1080\/19490976.2024.2447830","article-title":"Homeostatic pockets of interferon lambda-stimulated gene production in the intestine are associated with localized exposure to bacterial microbiota","volume":"17","year":"2025","journal-title":"Gut Microbes"},{"key":"B82","doi-asserted-by":"crossref","first-page":"e74072","DOI":"10.7554\/eLife.74072","article-title":"Homeostatic interferon-lambda response to bacterial microbiota stimulates preemptive antiviral defense within discrete pockets of intestinal epithelium","volume":"11","year":"2022","journal-title":"eLife"},{"issue":"2","key":"B83","doi-asserted-by":"crossref","first-page":"115243","DOI":"10.1016\/j.celrep.2025.115243","article-title":"Homeostatic antiviral protection of the neonatal gut epithelium by interferon lambda","volume":"44","year":"2025","journal-title":"Cell Rep"},{"issue":"20","key":"B84","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.1038\/s44318-025-00539-5","article-title":"Basal IFN-\u03bb2\/3 expression mediates tight junction formation in human epithelial cells","volume":"44","year":"2025","journal-title":"EMBO J"},{"key":"B85","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1146\/annurev-virology-111821-115754","article-title":"Impact of the microbiota on viral infections","volume":"10","year":"2023","journal-title":"Annu. Rev. Virol."},{"issue":"6","key":"B86","doi-asserted-by":"crossref","first-page":"e39080","DOI":"10.1371\/journal.pone.0039080","article-title":"Activation of type III interferon genes by pathogenic bacteria in infected epithelial cells and mouse placenta","volume":"7","year":"2012","journal-title":"PLOS ONE"},{"key":"B87","doi-asserted-by":"crossref","first-page":"624094","DOI":"10.3389\/fcimb.2021.624094","article-title":"Interferons: tug of war between bacteria and their host","volume":"11","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"1","key":"B88","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41385-021-00450-2","article-title":"STAT1 coordinates intestinal epithelial cell death during gastrointestinal infection upstream of Caspase-8","volume":"15","year":"2022","journal-title":"Mucosal Immunol"},{"key":"B89","doi-asserted-by":"crossref","first-page":"608","DOI":"10.3389\/fimmu.2019.00608","article-title":"Plasmacytoid dendritic cells provide protection against bacterial-induced colitis","volume":"10","year":"2019","journal-title":"Front. Immunol."},{"issue":"13","key":"B90","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1016\/j.cell.2022.04.028","article-title":"A family of conserved bacterial virulence factors dampens interferon responses by blocking calcium signaling","volume":"185","year":"2022","journal-title":"Cell"},{"issue":"1","key":"B91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcmgh.2019.02.007","article-title":"Interferon-\u03bb3 promotes epithelial defense and barrier function against Cryptosporidium parvum infection","volume":"8","year":"2019","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"5","key":"B92","doi-asserted-by":"crossref","first-page":"e1010003","DOI":"10.1371\/journal.ppat.1010003","article-title":"A genetic screen identifies a protective type III interferon response to Cryptosporidium that requires TLR3 dependent recognition","volume":"18","year":"2022","journal-title":"PLOS Pathog"},{"issue":"1","key":"B93","doi-asserted-by":"crossref","first-page":"2297897","DOI":"10.1080\/19490976.2023.2297897","article-title":"Cryptosporidium infection of human small intestinal epithelial cells induces type III interferon and impairs infectivity of Rotavirus","volume":"16","year":"2024","journal-title":"Gut Microbes"},{"key":"B94","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/s41467-023-37129-0","article-title":"Cryptosporidium uses CSpV1 to activate host type I interferon and attenuate antiparasitic defenses","volume":"14","year":"2023","journal-title":"Nat. Commun."},{"key":"B95","article-title":"IFN-\u03bb is protective against lethal oral Toxoplasma gondii infection","year":"2023"},{"key":"B96","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.3389\/fimmu.2018.02353","article-title":"Elevated systemic and parasite\u2013antigen stimulated levels of type III IFNs in a chronic helminth infection and reversal following anthelmintic treatment","volume":"9","year":"2018","journal-title":"Front. Immunol."},{"issue":"4","key":"B97","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.immuni.2022.03.009","article-title":"Epithelial STAT6 O-GlcNAcylation drives a concerted anti-helminth alarmin response dependent on tuft cell hyperplasia and Gasdermin C","volume":"55","year":"2022","journal-title":"Immunity"},{"issue":"26","key":"B98","doi-asserted-by":"crossref","first-page":"7533","DOI":"10.1016\/j.cell.2024.10.010","article-title":"Type III interferons induce pyroptosis in gut epithelial cells and impair mucosal repair","volume":"187","year":"2024","journal-title":"Cell"},{"issue":"1","key":"B99","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/j.gastro.2017.03.015","article-title":"Activation of epithelial signal transducer and activator of transcription 1 by interleukin 28 controls mucosal healing in mice with colitis and is increased in mucosa of patients with inflammatory bowel disease","volume":"153","year":"2017","journal-title":"Gastroenterology"},{"issue":"5","key":"B100","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1053\/j.gastro.2019.07.031","article-title":"Interferon lambda promotes Paneth cell death via STAT1 signaling in mice and is increased in inflamed ileal tissues of patients with Crohn's disease","volume":"157","year":"2019","journal-title":"Gastroenterology"},{"key":"B101","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1038\/s41467-019-10769-x","article-title":"Conserved transcriptomic profile between mouse and human colitis allows unsupervised patient stratification","volume":"10","year":"2019","journal-title":"Nat. Commun."},{"key":"B102","article-title":"Variants in interferon lambda are associated with very early onset inflammatory bowel disease","year":"2022"},{"key":"B103","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1038\/s41467-021-22928-0","article-title":"Critical role of interferons in gastrointestinal injury repair","volume":"12","year":"2021","journal-title":"Nat. Commun."},{"key":"B104","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1146\/annurev-virology-111821-112317","article-title":"Immunomodulation by enteric viruses","volume":"10","year":"2023","journal-title":"Annu. Rev. Virol."},{"issue":"7529","key":"B105","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature13960","article-title":"An enteric virus can replace the beneficial function of commensal bacteria","volume":"516","year":"2014","journal-title":"Nature"},{"issue":"70","key":"B106","doi-asserted-by":"crossref","first-page":"eabn6660","DOI":"10.1126\/sciimmunol.abn6660","article-title":"Human enteric viruses autonomously shape inflammatory bowel disease phenotype through divergent innate immunomodulation","volume":"7","year":"2022","journal-title":"Sci. Immunol."},{"issue":"2","key":"B107","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.cell.2004.07.002","article-title":"Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis","volume":"118","year":"2004","journal-title":"Cell"},{"issue":"4","key":"B108","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.immuni.2016.03.009","article-title":"Enteric viruses ameliorate gut inflammation via Toll-like receptor 3 and Toll-like receptor 7-mediated interferon-\u03b2 production","volume":"44","year":"2016","journal-title":"Immunity"},{"issue":"3","key":"B109","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.4049\/jimmunol.182.3.1296","article-title":"Differentiated human alveolar type II cells secrete antiviral IL-29 (IFN-\u03bb1) in response to influenza A infection","volume":"182","year":"2009","journal-title":"J. Immunol."},{"issue":"8","key":"B110","doi-asserted-by":"crossref","first-page":"e20210583","DOI":"10.1084\/jem.20210583","article-title":"Dynamic innate immune response determines susceptibility to SARS-CoV-2 infection and early replication kinetics","volume":"218","year":"2021","journal-title":"J. Exp. Med."},{"issue":"6","key":"B111","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1089\/jir.2019.0265","article-title":"Interferon-\u03bb receptor expression: novel reporter mouse reveals within- and cross-tissue heterogeneity","volume":"40","year":"2020","journal-title":"J. Interferon Cytokine Res."},{"issue":"3","key":"B112","doi-asserted-by":"crossref","first-page":"e0141324","DOI":"10.1128\/jvi.01413-24","article-title":"Single-cell transcriptomics reveals a compartmentalized antiviral interferon response in the nasal epithelium of mice","volume":"99","year":"2025","journal-title":"J. Virol."},{"issue":"11","key":"B113","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.it.2024.09.011","article-title":"Regional specialization within the mammalian respiratory immune system","volume":"45","year":"2024","journal-title":"Trends Immunol"},{"issue":"5","key":"B114","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.immuni.2017.04.025","article-title":"Interferon-\u03bb mediates non-redundant front-line antiviral protection against influenza virus infection without compromising host fitness","volume":"46","year":"2017","journal-title":"Immunity"},{"key":"B115","doi-asserted-by":"crossref","first-page":"e33354","DOI":"10.7554\/eLife.33354","article-title":"IFN-\u03bb prevents influenza virus spread from the upper airways to the lungs and limits virus transmission","volume":"7","year":"2018","journal-title":"eLife"},{"issue":"8","key":"B116","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/s41590-019-0408-z","article-title":"Interferon-\u03bb modulates dendritic cells to facilitate T cell immunity during infection with influenza A virus","volume":"20","year":"2019","journal-title":"Nat. Immunol."},{"issue":"5","key":"B117","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41590-019-0345-x","article-title":"Interferon-\u03bb enhances adaptive mucosal immunity by boosting release of thymic stromal lymphopoietin","volume":"20","year":"2019","journal-title":"Nat. Immunol."},{"issue":"6","key":"B118","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.chom.2020.05.008","article-title":"Type I and type III interferons \u2013 induction, signaling, evasion, and application to combat COVID-19","volume":"27","year":"2020","journal-title":"Cell Host Microbe"},{"key":"B119","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.coviro.2021.08.004","article-title":"Interfering with SARS-CoV-2: Are interferons friends or foes in COVID-19?","volume":"50","year":"2021","journal-title":"Curr. Opin. Virol."},{"issue":"19","key":"B120","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.1016\/j.cell.2021.08.016","article-title":"The interferon landscape along the respiratory tract impacts the severity of COVID-19","volume":"184","year":"2021","journal-title":"Cell"},{"key":"B121","doi-asserted-by":"crossref","first-page":"102423","DOI":"10.1016\/j.coi.2024.102423","article-title":"Yin and yang of interferons: lessons from the coronavirus disease 2019 (COVID-19) pandemic","volume":"87","year":"2024","journal-title":"Curr. Opin. Immunol."},{"issue":"2","key":"B122","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41590-021-01113-x","article-title":"Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection","volume":"23","year":"2022","journal-title":"Nat. Immunol."},{"key":"B123","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1038\/s41467-023-38682-4","article-title":"Persistent serum protein signatures define an inflammatory subcategory of long COVID","volume":"14","year":"2023","journal-title":"Nat. Commun."},{"issue":"21","key":"B124","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.1016\/j.cell.2023.08.044","article-title":"Multi-omics analysis of mucosal and systemic immunity to SARS-CoV-2 after birth","volume":"186","year":"2023","journal-title":"Cell"},{"issue":"5","key":"B125","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/s41564-024-01658-1","article-title":"Age-specific nasal epithelial responses to SARS-CoV-2 infection","volume":"9","year":"2024","journal-title":"Nat. Microbiol."},{"key":"B126","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1146\/annurev-immunol-101921-050835","article-title":"Interfering with interferons: a critical mechanism for critical COVID-19 pneumonia","volume":"41","year":"2023","journal-title":"Annu. Rev. Immunol."},{"issue":"7866","key":"B127","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41586-021-03631-y","article-title":"Diverse functional autoantibodies in patients with COVID-19","volume":"595","year":"2021","journal-title":"Nature"},{"issue":"9","key":"B128","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1089\/jir.2023.0003","article-title":"Autoantibodies neutralizing type III interferons are uncommon in patients with severe coronavirus disease 2019 pneumonia","volume":"43","year":"2023","journal-title":"J. Interferon Cytokine Res."},{"issue":"7","key":"B129","doi-asserted-by":"crossref","first-page":"e289","DOI":"10.1371\/journal.pmed.0030289","article-title":"Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1","volume":"3","year":"2006","journal-title":"PLOS Med"},{"issue":"23","key":"B130","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1182\/blood-2010-05-286161","article-title":"Anti-cytokine autoantibodies are associated with opportunistic infection in patients with thymic neoplasia","volume":"116","year":"2010","journal-title":"Blood"},{"issue":"3","key":"B131","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.cell.2016.06.024","article-title":"AIRE-deficient patients harbor unique high-affinity disease-ameliorating autoantibodies","volume":"166","year":"2016","journal-title":"Cell"},{"issue":"1","key":"B132","doi-asserted-by":"crossref","first-page":"100894","DOI":"10.1016\/j.xcrm.2022.100894","article-title":"Inactive disease in patients with lupus is linked to autoantibodies to type I interferons that normalize blood IFN\u03b1 and B cell subsets","volume":"4","year":"2023","journal-title":"Cell Rep. Med."},{"issue":"9","key":"B133","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nm1462","article-title":"Role of deficient type III interferon-\u03bb production in asthma exacerbations","volume":"12","year":"2006","journal-title":"Nat. Med."},{"issue":"1\u20132","key":"B134","first-page":"360","article-title":"Type-III interferon, not type-I, is the predominant interferon induced by respiratory viruses in nasal epithelial cells","volume":"160","year":"2011","journal-title":"Virus Res"},{"issue":"24","key":"B135","doi-asserted-by":"crossref","first-page":"12309","DOI":"10.1128\/JVI.02119-15","article-title":"Induction and antagonism of antiviral responses in respiratory syncytial virus-infected pediatric airway epithelium","volume":"89","year":"2015","journal-title":"J. Virol."},{"issue":"2","key":"B136","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1128\/JVI.01213-12","article-title":"Critical role of MDA5 in the interferon response induced by human metapneumovirus infection in dendritic cells and in vivo","volume":"87","year":"2013","journal-title":"J. Virol."},{"issue":"5","key":"B137","first-page":"e00550","article-title":"IFN-\u03bb drives distinct lung immune landscape changes and antiviral responses in human metapneumovirus infection","volume":"15","year":"2024","journal-title":"mBio"},{"issue":"6","key":"B138","first-page":"2948","article-title":"Parainfluenza virus 3 blocks antiviral mediators downstream of the interferon lambda receptor by modulating Stat1 phosphorylation","volume":"90","year":"2015","journal-title":"J. Virol."},{"issue":"18","key":"B139","doi-asserted-by":"crossref","first-page":"9140","DOI":"10.1128\/JVI.00717-10","article-title":"Alpha\/beta interferon (IFN-\u03b1\/\u03b2)-independent induction of IFN-\u03bb1 (interleukin-29) in response to Hantaan virus infection","volume":"84","year":"2010","journal-title":"J. Virol."},{"issue":"3","key":"B140","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41435-018-0028-x","article-title":"IFN-\u03bbs inhibit Hantaan virus infection through the JAK-STAT pathway and expression of Mx2 protein","volume":"20","year":"2019","journal-title":"Genes Immun"},{"issue":"4","key":"B141","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s12250-020-00330-2","article-title":"Herpesviruses and the type III interferon system","volume":"36","year":"2021","journal-title":"Virol. Sin."},{"issue":"6","key":"B142","doi-asserted-by":"crossref","first-page":"e38683","DOI":"10.1371\/journal.pone.0038683","article-title":"HHV-6B induces IFN-lambda1 responses in cord plasmacytoid dendritic cells through TLR9","volume":"7","year":"2012","journal-title":"PLOS ONE"},{"issue":"8","key":"B143","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3390\/v11080757","article-title":"IFN-\u03bb decreases murid herpesvirus-4 infection of the olfactory epithelium but fails to prevent virus reactivation in the vaginal mucosa","volume":"11","year":"2019","journal-title":"Viruses"},{"issue":"13","key":"B144","first-page":"e00099","article-title":"Middle East respiratory syndrome coronavirus nucleocapsid protein suppresses type I and type III interferon induction by targeting RIG-I signaling","volume":"94","year":"2020","journal-title":"J. Virol."},{"issue":"6","key":"B145","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1099\/jgv.0.000443","article-title":"Coxsackievirus counters the host innate immune response by blocking type III interferon expression","volume":"97","year":"2016","journal-title":"J. Gen. Virol."},{"issue":"6","key":"B146","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa2209760","article-title":"Early treatment with pegylated interferon lambda for Covid-19","volume":"388","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"B147","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1038\/s41467-024-48556-y","article-title":"Sustained IFN signaling is associated with delayed development of SARS-CoV-2-specific immunity","volume":"15","year":"2024","journal-title":"Nat. Commun."},{"issue":"16","key":"B148","doi-asserted-by":"crossref","first-page":"eaan5357","DOI":"10.1126\/sciimmunol.aan5357","article-title":"Type III interferon is a critical regulator of innate antifungal immunity","volume":"2","year":"2017","journal-title":"Sci. Immunol."},{"key":"B149","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3389\/fcimb.2020.00321","article-title":"Dectin-1 promotes type I and III interferon expression to support optimal antifungal immunity in the lung","volume":"10","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"105","key":"B150","doi-asserted-by":"crossref","first-page":"eadr0547","DOI":"10.1126\/sciimmunol.adr0547","article-title":"GM-CSF\u2013mediated epithelial-immune cell cross-talk orchestrates pulmonary immunity to Aspergillus fumigatus","volume":"10","year":"2025","journal-title":"Sci. Immunol."},{"key":"B151","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.molimm.2019.12.003","article-title":"Interleukin-22 regulates interferon lambda expression in a mice model of Pseudomonas aeruginosa pneumonia","volume":"118","year":"2020","journal-title":"Mol. Immunol."},{"issue":"2","key":"B152","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1165\/rcmb.2018-0021OC","article-title":"The effects of IFN-\u03bb on epithelial barrier function contribute to Klebsiella pneumoniae ST258 pneumonia","volume":"60","year":"2019","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"8","key":"B153","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.4049\/jimmunol.1900912","article-title":"Age-dependent effects of type I and type III IFNs in the pathogenesis of Bordetella pertussis infection and disease","volume":"204","year":"2020","journal-title":"J. Immunol."},{"issue":"10","key":"B154","first-page":"e00352","article-title":"Differential induction of type I and III interferons by Staphylococcus aureus","volume":"88","year":"2020","journal-title":"Infect. Immun."},{"issue":"5","key":"B155","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1159\/000522232","article-title":"The capsule of Acinetobacter baumannii protects against the innate immune response","volume":"14","year":"2022","journal-title":"J. Innate Immun."},{"issue":"51","key":"B156","doi-asserted-by":"crossref","first-page":"e2105170118","DOI":"10.1073\/pnas.2105170118","article-title":"Microbiome-mediated incapacitation of interferon lambda production in the oral mucosa","volume":"118","year":"2021","journal-title":"PNAS"},{"issue":"10","key":"B157","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1002\/eji.201847556","article-title":"IL-1\u03b2 activation in response to Staphylococcus aureus lung infection requires inflammasome-dependent and independent mechanisms","volume":"48","year":"2018","journal-title":"Eur. J. Immunol."},{"issue":"4","key":"B158","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.jaci.2018.09.041","article-title":"IFN-\u03bb1 enhances Staphylococcus aureus clearance in healthy nasal mucosa but not in nasal polyps","volume":"143","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"issue":"6504","key":"B159","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1126\/science.abc3545","article-title":"Type III interferons disrupt the lung epithelial barrier upon viral recognition","volume":"369","year":"2020","journal-title":"Science"},{"issue":"6504","key":"B160","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1126\/science.abc2061","article-title":"Type I and III interferons disrupt lung epithelial repair during recovery from viral infection","volume":"369","year":"2020","journal-title":"Science"},{"issue":"8","key":"B161","first-page":"e01667","article-title":"SARS-CoV-2 infection predisposes patients to coinfection with Staphylococcus aureus","volume":"15","year":"2024","journal-title":"mBio"},{"issue":"8","key":"B162","doi-asserted-by":"crossref","first-page":"e1012498","DOI":"10.1371\/journal.ppat.1012498","article-title":"Cell-intrinsic regulation of phagocyte function by interferon lambda during pulmonary viral, bacterial super-infection","volume":"20","year":"2024","journal-title":"PLOS Pathog"},{"issue":"5","key":"B163","first-page":"e00114","article-title":"Interferon lambda inhibits bacterial uptake during influenza superinfection","volume":"87","year":"2019","journal-title":"Infect. Immun."},{"key":"B164","doi-asserted-by":"crossref","first-page":"764062","DOI":"10.3389\/fimmu.2021.764062","article-title":"Type III interferons: emerging roles in autoimmunity","volume":"12","year":"2021","journal-title":"Front. Immunol."},{"issue":"6","key":"B165","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/emmm.201100142","article-title":"IL-28A (IFN-\u03bb2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease","volume":"3","year":"2011","journal-title":"EMBO Mol. Med."},{"key":"B166","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.cyto.2019.02.010","article-title":"Inhaled delivery of Interferon-lambda restricts epithelial-derived Th2 inflammation in allergic asthma","volume":"119","year":"2019","journal-title":"Cytokine"},{"issue":"3","key":"B167","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.lungcan.2012.09.005","article-title":"Potential anti-tumor effect of IFN-\u03bb2 (IL-28A) against human lung cancer cells","volume":"78","year":"2012","journal-title":"Lung Cancer"},{"issue":"11","key":"B168","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1111\/j.1349-7006.2011.02079.x","article-title":"Antitumor activity of type III interferon alone or in combination with type I interferon against human non-small cell lung cancer","volume":"102","year":"2011","journal-title":"Cancer Sci"},{"key":"B169","first-page":"1525083","article-title":"IFN\u03bb1 is a STING-dependent mediator of DNA damage and induces immune activation in lung cancer","volume":"15","year":"2024","journal-title":"Front. Immunol."},{"issue":"3","key":"B170","doi-asserted-by":"crossref","first-page":"152389","DOI":"10.1016\/j.imbio.2023.152389","article-title":"PD-L1 and PD-L2 immune checkpoint protein induction by type III interferon in non-small cell lung cancer cells","volume":"228","year":"2023","journal-title":"Immunobiology"},{"issue":"12","key":"B171","doi-asserted-by":"crossref","first-page":"7686","DOI":"10.4049\/jimmunol.176.12.7686","article-title":"Antitumor activity of IFN-\u03bb in murine tumor models","volume":"176","year":"2006","journal-title":"J. Immunol."},{"issue":"8","key":"B172","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.4049\/jimmunol.178.8.5086","article-title":"IL-28 elicits antitumor responses against murine fibrosarcoma","volume":"178","year":"2007","journal-title":"J. Immunol."},{"issue":"31","key":"B173","doi-asserted-by":"crossref","first-page":"eaat6114","DOI":"10.1126\/sciimmunol.aat6114","article-title":"Immune responses at the maternal-fetal interface","volume":"4","year":"2019","journal-title":"Sci. Immunol."},{"issue":"29","key":"B174","doi-asserted-by":"crossref","first-page":"12048","DOI":"10.1073\/pnas.1304718110","article-title":"Human placental trophoblasts confer viral resistance to recipient cells","volume":"110","year":"2013","journal-title":"PNAS"},{"key":"B175","doi-asserted-by":"crossref","first-page":"e79794","DOI":"10.7554\/eLife.79794","article-title":"Innate immune signaling in trophoblast and decidua organoids defines differential antiviral defenses at the maternal-fetal interface","volume":"11","year":"2022","journal-title":"eLife"},{"issue":"5","key":"B176","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.chom.2016.03.008","article-title":"Type III interferons produced by human placental trophoblasts confer protection against Zika virus infection","volume":"19","year":"2016","journal-title":"Cell Host Microbe"},{"issue":"1","key":"B177","doi-asserted-by":"crossref","first-page":"71.e1","DOI":"10.1016\/j.ajog.2014.07.060","article-title":"Human trophoblasts confer resistance to viruses implicated in perinatal infection","volume":"212","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"35","key":"B178","doi-asserted-by":"crossref","first-page":"9433","DOI":"10.1073\/pnas.1707513114","article-title":"Organotypic models of type III interferon-mediated protection from Zika virus infections at the maternal\u2013fetal interface","volume":"114","year":"2017","journal-title":"PNAS"},{"key":"B179","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41467-018-07993-2","article-title":"Interferon lambda protects the female reproductive tract against Zika virus infection","volume":"10","year":"2019","journal-title":"Nat. Commun."},{"issue":"3","key":"B180","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.chom.2017.08.012","article-title":"Gestational stage and IFN-\u03bb signaling regulate ZIKV infection in utero","volume":"22","year":"2017","journal-title":"Cell Host Microbe"},{"issue":"19","key":"B181","doi-asserted-by":"crossref","first-page":"eaao1680","DOI":"10.1126\/sciimmunol.aao1680","article-title":"Type I interferons instigate fetal demise after Zika virus infection","volume":"3","year":"2018","journal-title":"Sci. Immunol."},{"issue":"3","key":"B182","first-page":"e03857","article-title":"Interferon lambda signals in maternal tissues to exert protective and pathogenic effects in a gestational stage-dependent manner","volume":"13","year":"2022","journal-title":"mBio"},{"issue":"2","key":"B183","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41579-021-00610-y","article-title":"Infections at the maternal\u2013fetal interface: an overview of pathogenesis and defence","volume":"20","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"issue":"9","key":"B184","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.1128\/JVI.02591-09","article-title":"Expression of type III interferon (IFN) in the vaginal mucosa is mediated primarily by dendritic cells and displays stronger dependence on NF-\u03baB than type I IFNs","volume":"84","year":"2010","journal-title":"J. Virol."},{"issue":"9","key":"B185","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1128\/JVI.80.9.4501-4509.2006","article-title":"Lambda interferon (IFN-\u03bb), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo","volume":"80","year":"2006","journal-title":"J. Virol."},{"issue":"12","key":"B186","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1093\/molehr\/gav058","article-title":"Induction of interferon-\u03bb contributes to TLR3 and RIG-I activation-mediated inhibition of herpes simplex virus type 2 replication in human cervical epithelial cells","volume":"21","year":"2015","journal-title":"Mol. Hum. Reprod."},{"key":"B187","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.1038\/s41467-018-07200-2","article-title":"Genotype specific pathogenicity of hepatitis E virus at the human maternal-fetal interface","volume":"9","year":"2018","journal-title":"Nat. Commun."},{"issue":"9","key":"B188","doi-asserted-by":"crossref","first-page":"e40267","DOI":"10.1371\/journal.pone.0040267","article-title":"Identification of pro-inflammatory cytokines associated with muscle invasive bladder cancer; the roles of IL-5, IL-20, and IL-28A","volume":"7","year":"2012","journal-title":"PLOS ONE"},{"issue":"9","key":"B189","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/j.cellsig.2012.04.013","article-title":"Interleukin-28A triggers wound healing migration of bladder cancer cells via NF-\u03baB-mediated MMP-9 expression inducing the MAPK pathway","volume":"24","year":"2012","journal-title":"Cellular Signal"},{"issue":"4","key":"B190","doi-asserted-by":"crossref","first-page":"e007808","DOI":"10.1136\/jitc-2023-007808","article-title":"Type III interferon inhibits bladder cancer progression by reprogramming macrophage-mediated phagocytosis and orchestrating effective immune responses","volume":"12","year":"2024","journal-title":"J. ImmunoTher. Cancer"},{"issue":"9","key":"B191","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.humimm.2023.06.001","article-title":"Interferon lambda modulates proinflammatory cytokines production in PBMCs from patients with chronic kidney disease","volume":"84","year":"2023","journal-title":"Hum. Immunol."},{"issue":"3","key":"B192","doi-asserted-by":"crossref","first-page":"R88","DOI":"10.1186\/ar3363","article-title":"Interferon-lambda1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus: its correlation with disease activity","volume":"13","year":"2011","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"B193","doi-asserted-by":"crossref","first-page":"e000170","DOI":"10.1136\/lupus-2016-000170","article-title":"Interferon (IFN)-\u03bb is a potential mediator in lupus nephritis","volume":"3","year":"2016","journal-title":"Lupus Sci. Med."},{"issue":"1","key":"B194","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s13075-018-1683-z","article-title":"Interferon-\u03bb3\/4 genetic variants and interferon-\u03bb3 serum levels are biomarkers of lupus nephritis and disease activity in Taiwanese","volume":"20","year":"2018","journal-title":"Arthritis Res. Ther."},{"issue":"11","key":"B195","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.4049\/jimmunol.2100339","article-title":"2021. B cell activation and plasma cell differentiation are promoted by IFN-\u03bb in systemic lupus erythematosus","volume":"207","journal-title":"J. Immunol."},{"issue":"4","key":"B196","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.immuni.2018.08.015","article-title":"Distinct effector B cells induced by unregulated Toll-like receptor 7 contribute to pathogenic responses in systemic lupus erythematosus","volume":"49","year":"2018","journal-title":"Immunity"},{"issue":"21","key":"B197","doi-asserted-by":"crossref","first-page":"11747","DOI":"10.3390\/ijms222111747","article-title":"Interferon lambda regulates cellular and humoral immunity in pristane-induced lupus","volume":"22","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"B198","first-page":"e02623","article-title":"Interferon lambda restricts herpes simplex virus skin disease by suppressing neutrophil-mediated pathology","volume":"15","year":"2024","journal-title":"mBio"},{"issue":"1","key":"B199","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.immuni.2013.12.010","article-title":"Immune responses to HCV and other hepatitis viruses","volume":"40","year":"2014","journal-title":"Immunity"},{"issue":"6","key":"B200","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1002\/hep.24580","article-title":"Hepatitis C virus induces interferon-\u03bb and interferon-stimulated genes in primary liver cultures","volume":"54","year":"2010","journal-title":"Hepatology"},{"issue":"6","key":"B201","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1002\/hep.25897","article-title":"IL-29 is the dominant type III interferon produced by hepatocytes during acute hepatitis C virus infection","volume":"56","year":"2012","journal-title":"Hepatology"},{"issue":"1","key":"B202","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.immuni.2014.12.016","article-title":"The RNA sensor RIG-I dually functions as an innate sensor and direct antiviral factor for hepatitis B virus","volume":"42","year":"2015","journal-title":"Immunity"},{"issue":"9","key":"B203","doi-asserted-by":"crossref","first-page":"e1000151","DOI":"10.1371\/journal.ppat.1000151","article-title":"Interferon-\u03bb contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses","volume":"4","year":"2008","journal-title":"PLOS Pathog"},{"issue":"1","key":"B204","doi-asserted-by":"crossref","first-page":"e87906","DOI":"10.1371\/journal.pone.0087906","article-title":"Human but not mouse hepatocytes respond to interferon-lambda in vivo","volume":"9","year":"2014","journal-title":"PLOS ONE"},{"issue":"10","key":"B205","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1089\/jir.2019.0043","article-title":"Genetics of the human interferon lambda region","volume":"39","year":"2019","journal-title":"J. Interferon Cytokine Res."},{"issue":"6","key":"B206","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1002\/hep.29395","article-title":"Interferon lambda 4 rs368234815 TT>\u03b4G variant is associated with liver damage in patients with nonalcoholic fatty liver disease","volume":"66","year":"2017","journal-title":"Hepatology"},{"issue":"1","key":"B207","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/ni.2758","article-title":"The favorable IFNL3 genotype escapes mRNA decay mediated by AU-rich elements and hepatitis C virus-induced microRNAs","volume":"15","year":"2014","journal-title":"Nat. Immunol."},{"issue":"6","key":"B208","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.jhep.2014.07.022","article-title":"A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection","volume":"61","year":"2014","journal-title":"J. Hepatol."},{"key":"B209","doi-asserted-by":"crossref","first-page":"102389","DOI":"10.1016\/j.coi.2023.102389","article-title":"The role of interferon in the thymus","volume":"84","year":"2023","journal-title":"Curr. Opin. Immunol."},{"issue":"5","key":"B210","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.4049\/jimmunol.2000225","article-title":"IFN-\u03bb enhances constitutive expression of MHC class I molecules on thymic epithelial cells","volume":"205","year":"2020","journal-title":"J. Immunol."},{"issue":"7","key":"B211","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1093\/jimmun\/vkaf048","article-title":"Sterile production of interferons in the thymus","volume":"214","year":"2025","journal-title":"J. Immunol."}],"container-title":["Annual Review of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.annualreviews.org\/content\/journals\/10.1146\/annurev-immunol-083024-032807?crawler=true&mimetype=application\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T02:41:53Z","timestamp":1777344113000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.annualreviews.org\/content\/journals\/10.1146\/annurev-immunol-083024-032807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":211,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,4,27]]}},"URL":"https:\/\/doi.org\/10.1146\/annurev-immunol-083024-032807","relation":{},"ISSN":["0732-0582","1545-3278"],"issn-type":[{"value":"0732-0582","type":"print"},{"value":"1545-3278","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]}}}